pharma · Parkinson Disease · Tuberculosis · GANX
Gain Therapeutics
Gain Therapeutics clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Bethesda, USA
- Founded
- 2017
- Employees
- 28
- Programs
- 4
- Drugs
- 7
- Patents
- 27
Gain Therapeutics projects
4 ClinicalTrials.gov programs sponsored by Gain Therapeutics.
Gain Therapeutics has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Low Dose GT-02287
Gain Therapeutics
Parkinson Disease
1 trial -
GT-02287
Gain Therapeutics
Parkinson Disease
1 trial -
combined fixed dose combination
Gain Therapeutics
Tuberculosis
1 trial -
Envita Stories Methodology in Long-term care Centres for old adults
Gain Therapeutics
Long-term Care Centres for Old Adults Users
1 trial
Frequently asked questions
How many clinical projects does Gain Therapeutics have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.